$ENZY News
Last published 9y ago
- 9y agoENZYEnzymotec's (ENZY) CEO Erez Israeli on Q1 2017 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoENZYEnzymotec's (ENZY) CEO Dr. Ariel Katz on Q2 2016 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoENZYEnzymotec's (ENZY) CEO Ariel Katz on Q4 2015 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoIMSENZYIMS Health’s Nexxus Mobile Intelligence CRM Powers VAYA Pharma’s Commercial OperationsBusiness WireDANBURY, Conn.--(BUSINESS WIRE)--IMS Health (NYSE:IMS) today announced that VAYA Pharma, a specialty medical food division of Enzymotec Ltd. (NASDAQ:ENZY), has adopted IMS Health's Nexxus™ Mobile Intelligence CRM solution to support the successful expansion of VAYA's sales team and commercial operations. Designed for the life sciences market, this mobile field solution seamlessly integrates IMS He ...